EUVIMEDEUVIMED entdecken
Open Access

The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management

Irem Bilgetekin, Taha Bahsi, Yusuf Bahap, Mehmet Ali Ergün, Ibrahim Güllü

Cancer Diagnosis & Prognosis · 01.07.2026 · 6 (4) · 737-744

DOI: 10.21873/cdp.10574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.07.2026. Verfasst von Irem Bilgetekin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Uskudar University Faculty of Medicine, Istanbul, Turkey. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: With the expansion of next-generation sequencing (NGS)-based hereditary cancer panels, this study aimed to: (i) identify non-BRCA predisposition genes in an index case with three different primary cancers; (ii) demonstrate the clinical utility of cascade testing via comprehensive panel NGS testing for early cancer detection in asymptomatic relatives; (iii) discuss the potential association between a co-segregating MITF variant and a family history of recurrent meningioma; and (iv) provide a practical management framework for Multilocus Inherited Neoplasia Allele Syndrome (MINAS) in the context of dual ATM+MITF carriership. Materials and Methods: Index patient and family members who have a history of cancer with a familial cancer pedigree were evaluated using a multigene NGS approach. Targeted sequencing was performed on the MGI DNBSEQ-G400 platform using the Twist Bioscience Hereditary Cancer Panel.

Results

A germline ATM variant was identified in the index case, and ATM carrier status was confirmed in his two sons. During cascade screening, early-stage colon cancer was detected on colonoscopy in one son, while prostate cancer was diagnosed in the other. MITF carrier status was identified in three family members; among them, the index patient’s sister and one nephew had a history of meningioma, and the nephew was also shown to be an ATM carrier. A history of meningioma was also present in another family member with an MITF variant.

Conclusion

Large-panel NGS testing in cancer patients is transforming family-based risk management by enabling the identification of homologous recombination repair (HRR) genes (including ATM) beyond BRCA1/2. Cascade testing via comprehensive NGS provides tangible clinical benefits by detecting malignancies early in clinically silent carriers.

Schlagwörter

Stichwörter der Autor:innen

ATMHereditary cancersMITFmeningiomaprostate cancer

Autor:innen und Institutionen

  • Department of Internal Medicine, Uskudar University Faculty of Medicine, Istanbul, Turkey.
  • Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkey.
  • Department of Medical Genetics, Memorial Ankara Hospital, Ankara, Turkey.
  • Department of Medical Genetics, Gazi University Faculty of Medicine, Ankara, Turkey.
  • Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Zitieren

APA

Bilgetekin, I., Bahsi, T., Bahap, Y., Ergün, M. A., & Güllü, I. (2026). The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management. Cancer Diagnosis & Prognosis, 6(4), 737-744. https://doi.org/10.21873/cdp.10574

Vancouver

Bilgetekin I, Bahsi T, Bahap Y, Ergün MA, Güllü I. The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management. Cancer Diagnosis & Prognosis. 2026;6(4):737-744. doi:10.21873/cdp.10574

BibTeX
@article{Bilgetekin2026,
  author = {Bilgetekin, Irem and Bahsi, Taha and Bahap, Yusuf and Ergün, Mehmet Ali and Güllü, Ibrahim},
  title = {The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {737--744},
  doi = {10.21873/cdp.10574}
}
Kostenlos starten →